Logo image
Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas
Journal article   Open access   Peer reviewed

Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

Gregory P Way, Francisco Sanchez-Vega, Konnor La, Joshua Armenia, Walid K Chatila, Augustin Luna, Chris Sander, Andrew D Cherniack, Marco Mina, Giovanni Ciriello, …
Cell reports (Cambridge), Vol.23(1), pp.172-180.e3
04/03/2018
DOI: 10.1016/j.celrep.2018.03.046
PMCID: PMC5918694
PMID: 29617658
url
https://doi.org/10.1016/j.celrep.2018.03.046View
Published (Version of record) Open Access

Abstract

Precision oncology uses genomic evidence to match patients with treatment but often fails to identify all patients who may respond. The transcriptome of these "hidden responders" may reveal responsive molecular states. We describe and evaluate a machine-learning approach to classify aberrant pathway activity in tumors, which may aid in hidden responder identification. The algorithm integrates RNA-seq, copy number, and mutations from 33 different cancer types across The Cancer Genome Atlas (TCGA) PanCanAtlas project to predict aberrant molecular states in tumors. Applied to the Ras pathway, the method detects Ras activation across cancer types and identifies phenocopying variants. The model, trained on human tumors, can predict response to MEK inhibitors in wild-type Ras cell lines. We also present data that suggest that multiple hits in the Ras pathway confer increased Ras activity. The transcriptome is underused in precision oncology and, combined with machine learning, can aid in the identification of hidden responders.
Machine Learning Signal Transduction Cell Line, Tumor Gene Expression Regulation, Neoplastic Genome, Human Humans Neoplasms - genetics Neoplasms - metabolism ras Proteins - genetics ras Proteins - metabolism

Details

Metrics

Logo image